Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan, providing innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of 17,000 + employees worldwide, Daiichi-Sankyo create innovative new and generic medicines, and new methods of drug discovery and delivery – sharing a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.

Britain’s Pothole Crisis: Could AI Save £17 billion?
As the cost of repairing Britain’s pothole-ridden roads nears £17 billion, AI could offer a smarter, more sustainable approach to tackling the crisis.





